<DOC>
	<DOCNO>NCT00315367</DOCNO>
	<brief_summary>The purpose study determine medication design improve memory help patient Multiple Sclerosis ( MS ) experience memory problem use fMRI track brain activity .</brief_summary>
	<brief_title>A fMRI ( Functional Magnetic Resonance Imaging ) Research Study Learn More About Multiple Sclerosis Individuals Potentially Experiencing Memory Difficulties</brief_title>
	<detailed_description>Donepezil HCI ( Aricept® ) FDA-approved drug use enhance memory patient Alzheimer 's disease . The aim project examine effect Donepezil HCI ( Aricept® ) memory induce brain activation pattern context double-blind , crossover trial patient multiple sclerosis ( MS ) . We perform task activation experiment involve two cognitive domain . The propose work MS patient yield new information regard functional anatomic relationship cognitive activity , relationship change function drug treatment .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Between 18 65 year age experience forgetfulness Diagnosed MS , currently take Rebif® experience mild memory problem Participants stable medication dosage 1 month prior test With past present neurological disorder ( e.g . head trauma , seizure , encephalitis , stroke ) except MS With known medical illness ( e.g . diabetes , uncontrolled hypertension , arthritis ) With psychiatric illness With current substance abuse Females pregnant nursing With metallic device body claustrophobia Previous history CNS disturbance MS Severe motor visual impairment might interfere cognitive activation task Prescribed psychoactive medication Memory deficit cause significant neurological disease psychiatric disorder Active malignancy within one year study participation Known human immunodeficiency virus ( HIV ) Current diagnosis unstable glaucoma ; history myocardial infarction Symptomatic Coronary Artery Disease within last 12 month evidence ongoing ischemia uncontrolled atrial ventricular arrhythmia show ECG ; poorly control labile hypertension History epilepsy seizure disorder within past 12 month Allergy hypersensitivity amphetamine sympathomimetic amine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Memory impairment</keyword>
</DOC>